Can We Really Cheat Death? The Science of Living Beyond 122

What if living past 122 isn’t just a dream — but a dangerous obsession?

The quest for extended life is no longer confined to science fiction; it’s a burgeoning industry fueled by scientific breakthroughs, public interest, and significant investment. From cellular reprogramming to senolytics, researchers are exploring various avenues to slow aging and extend human life.

However, despite the promise, the complexity of aging biology means success is far from guaranteed. Some therapies, like those targeting senescent cells, have shown promise in animal studies but failed in human trials. Meanwhile, the X Prize is offering $101 million for a treatment that can add a decade of healthy life to older adults — an ambitious goal that reflects both the potential and uncertainty in the field.

As the longevity industry pushes boundaries, we must ask: Is the pursuit of extreme life extension a path to better health, or are we venturing into uncharted and potentially perilous territory?

Read the full article on MIT Technology Review.

----

💡 We're entering a world where intelligence is synthetic, reality is augmented, and the rules are being rewritten in front of our eyes.

Staying up-to-date in a fast-changing world is vital. That is why I have launched Futurwise; a personalized AI platform that transforms information chaos into strategic clarity. With one click, users can bookmark and summarize any article, report, or video in seconds, tailored to their tone, interests, and language. Visit Futurwise.com to get started for free!